Is Lam Research (LRCX) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Lam Research (LRCX).Lam Research currently has an average brokerage recommendation (ABR) of 1.60, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 30 brokerage firms. An ABR of 1.60 approximates between Strong Buy and Buy.Of the 30 recommendations that derive the current ABR, 20 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 66.7% and 6.7% of all recommendations.Brokerage Recommendation Trends for LRCXCheck price target & stock forecast for Lam Research here>>>While the ABR calls for buying Lam Research, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five "Strong Buy" recommendations for every "Strong Sell" recommendation.This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements.With an impressive externally audited track record, our proprietary stock rating tool, the Zacks Rank, which classifies stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), is a reliable indicator of a stock's near -term price performance. So, validating the Zacks Rank with ABR could go a long way in making a profitable investment decision.ABR Should Not Be Confused With Zacks RankAlthough both Zacks Rank and ABR are displayed in a range of 1-5, they are different measures altogether.The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.In addition, the different Zacks Rank grades are applied proportionately to all stocks for which brokerage analysts provide current-year earnings estimates. In other words, this tool always maintains a balance among its five ranks.Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements.Should You Invest in LRCX?Looking at the earnings estimate revisions for Lam Research, the Zacks Consensus Estimate for the current year has increased 6.4% over the past month to $3.97.Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Lam Research. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Therefore, the Buy-equivalent ABR for Lam Research may serve as a useful guide for investors.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Lam Research Corporation (LRCX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Quelle: Zacks
Nachrichten zu Lam Research Corp.
Analysen zu Lam Research Corp.
Datum | Rating | Analyst | |
---|---|---|---|
25.04.2019 | Lam Research Outperform | Cowen and Company, LLC | |
22.04.2019 | Lam Research Buy | B. Riley FBR | |
24.01.2019 | Lam Research Outperform | Cowen and Company, LLC | |
21.12.2018 | Lam Research Buy | Needham & Company, LLC | |
29.10.2018 | Lam Research Neutral | B. Riley FBR |
Datum | Rating | Analyst | |
---|---|---|---|
25.04.2019 | Lam Research Outperform | Cowen and Company, LLC | |
22.04.2019 | Lam Research Buy | B. Riley FBR | |
24.01.2019 | Lam Research Outperform | Cowen and Company, LLC | |
21.12.2018 | Lam Research Buy | Needham & Company, LLC | |
17.10.2018 | Lam Research Outperform | Cowen and Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
29.10.2018 | Lam Research Neutral | B. Riley FBR | |
01.10.2018 | Lam Research Hold | Deutsche Bank AG | |
01.10.2018 | Lam Research Neutral | Mizuho | |
12.10.2016 | Lam Research Sector Weight | Pacific Crest Securities Inc. | |
21.04.2015 | Lam Research Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
22.10.2015 | Lam Research Underperform | RBC Capital Markets | |
05.10.2015 | Lam Research Underperform | RBC Capital Markets | |
11.11.2010 | Lam Research sell | Citigroup Corp. | |
29.07.2010 | Lam Research sell | Citigroup Corp. | |
19.03.2009 | Lam Research underperform | Credit Suisse Group |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Lam Research Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen